Merck & Co.

Janet Woodcock named acting commissioner of the FDA

During his time as FDA commissioner, Hahn co-ordinated the FDA’s response to the COVID-19 pandemic during what was a particularly turbulent time for the agency.

BMS aims for US approval of Opdivo combo in stomach cancer

If Opdivo wins an approval for first-line gastric cancer, it could gain an advantage over Merck &Co’s (MSD) rival checkpoint inhibitor Keytruda (pembrolizumab).

Trial failure for bintrafusp alfa casts doubt on GSK/Merck KGaA’s cancer alliance

In a statement, Merck said that the study’s Independent Data Monitoring Committee (IDMC) recommended that the trial should be discontinued, as it is ‘unlikely’ to meet the co-primary endpoint ... program,” said Danny Bar-Zohar, global head of

Merck’s appeal to restore hepatitis C patent verdict against Gilead fails

US Supreme Court rejects Merck’s appeal over patent dispute verdict of $2.54bn. ... Merck &Co’s appeal to restore a verdict against Gilead for infringing on a patent relating to a hepatitis C virus (HCV) treatment has been rejected by the US Supreme

Sourcing R&D innovation: why pharma companies need to evolve their business models

Similarly, Novartis formed the investment firm Novartis Venture Funds and Merck &Co. ... created the Merck Research Venture Fund. Nowadays, having a venture arm to proactively research for outside R&D sourcing is common for most mid- to large- sized

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]